Overall rank by patents
#45,114
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, active 2020–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C01B (NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; ; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C).
The verdict
BILL holds 5 US patents across 5 technology areas, rank #45,114 of 50,000 tracked assignees.
BILL Archer, Llc has been granted 5 US utility patents between 2020 and 2021, placing BILL Archer, Llc at rank #45,114 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.2 claims per patent with primary concentration in C01B (NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; ; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C). As a US Corporation, BILL Archer, Llc is one of the more focused assignees in the PatentsView dataset. By volume, BILL sits between Bifido Co., Ltd. (5 patents, rank #45,110) and Biocontrol Systems, Inc. (5 patents, rank #45,118) - the closest US assignees by grant volume. The composite Innovation Score of 22.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2021, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. BILL Archer, Llc's 14.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark BILL Archer, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
BIFIDO CO., LTD.
5 patents
BIG KAT BUGGY, LLC
5 patents
BIGLEVER SOFTWARE, INC.
5 patents
BILAB CO., LTD.
5 patents
BIO HEALTH FRONTIERS, INC.
5 patents
BIOAMBER INC.
5 patents
BIOATLANTIS LIMITED
5 patents
BIOCONTROL SYSTEMS, INC.
5 patents
BILL ARCHER, LLC
5 patents
What this shows BILL holds 5 patents at rank #45,114, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #45,114 in granted patent volume.
Other assignees with the most granted patents in BILL's primary technology class.
BILL's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
23 Top 89% higher than 11% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 4 | 80.0% |
| 2021 | 1 | 20.0% |
Top 5 of 5 technology areas
Overall rank by patents
#45,114
Across all tracked assignees
22.6 out of 100
How to use this portfolio
BILL's 5 grants land it in the top 89% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.